Vandan Foods IPO allotment to be out soon: Here are steps to check status online and GMP as focus shifts to listing
The proposed listing date for Vandan Foods' initial public offering (IPO) on the BSE SME is set for Monday, July 7, 2025.
Bigshare Services Pvt Ltd is the issue's registrar, while Nirbhay Capital Services Private Limited is the book-running lead manager for the Vandan Foods IPO. Aftertrade Broking Pvt Ltd is the market maker for the Vandan Foods initial public offering.
Since Bigshare Services Pvt. Ltd. is the registrar for the Vanda Foods IPO and the Vandan Foods shares are to be listed on the BSE SME , investors can check listing status on the registrar Bigshare Services Pvt. Ltd.'s website and also on the BSE website.
Here are steps to check status online and GMP as focus shifts to listing
Step 1: Go to the website of Registrar Bigshare Services Pvt Limited to check the PRO FX Tech allotment status by clicking the link:
Step 2: Select any one of the servers to check allotment status
Step 3: Select Vandan Foods Limited from the 'Select company' dropdown menu. (Note: the company name will only appear once the allotment status is out.)
Step 4: Select from the selection type any of the following: DP ID or Client ID, application number or CAF number, or the PAN number
Step 5: Enter the details from the option selected on the Value Box
Step 6: Click on the search button after entering the CAPTCHA.
Step 1: Head to the BSE website:
Step 2: Select Issue type and click on Equity
Step 3: Under the select issue name, select "VANDAN FOODS LIMITED" from the dropdown
Step 4: Thereafter, enter your details, such as application number and PAN information.
Step 5: Press 'Submit' after clicking the CAPTCHA
Vandan Foods IPO GMP (grey market premium) stands at NIL This means that the Vandan Foods shares are commanding no premium over the issue price of ₹ 115 in the grey market, according to data from investorgain.com. The same also indicates that the listing of Vandan Foodshares is anticipated to be without any premium over the upper range of the offer price of ₹ 115 per share, also indicating that market players are anticipating Nil listing gains.
Disclaimer: The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
4 hours ago
- Mint
Mahindra Holidays shares to be in focus on Friday after acquiring 100% stake in Finland-based real estate firm
Mahindra Group-owned hotel subsidiary, Mahindra Holidays & Resorts India, shares will be in focus of the stock market investors on Friday, 4 July 2025, after the company acquired a 100% stake in a Finland-based mutual real estate firm, Keskinainen Kiinteistcö Oy Salla Star, according to an exchange filing. The company acquired the Finnish firm for nearly ₹ 23.5 million, according to the filing data. 'We would like to inform you that Holiday Club Resorts Oy, incorporated in Finland, which in turn is a wholly owned subsidiary of Covington S.a.r.l., which in turn is a wholly owned subsidiary of MHR Holdings (Mauritius) Limited, which in turn is a wholly owned subsidiary of Mahindra Holidays & Resorts India Limited, has executed a Share Purchase Agreement (SPA) with shareholders of Keskinainen Kiinteistcö Oy Salla Star,, Finland to acquire 100% stake in KKOSS today i.e. 3 July 2025,' said Mahindra Holidays in the BSE filing. The Keskinainen Kiinteistö Oy Salla Star is a Finnish mutual real estate firm whose primary business is owning and managing a property located in 'Block 26' in the village of Markajarvi in Salla, Finland. The company makes an annual turnover of a little over ₹ 5.13 lakh as of the year ended 31 December 2024. The firm has a net worth of ₹ 2.37 lakh as of the same period, according to the BSE filing. The company disclosed that the 'acquisition doesn't fall within related party transaction(s).' However, the deal has been carried out through multiple subsidiaries of the Maindra Group firms. Mahindra Holidays & Resorts shares closed 0.80% higher at ₹ 341 after Thursday's stock market session, compared to ₹ 338.30 at the previous market close. The company announced the acquisition move after market operating hours on 3 July 2025. Mahindra Holidays & Resorts shares have given stock market investors more than 185% returns on their investment in the last five years. However, the stock is down 25% in the last one-year period. On a year-to-date (YTD) basis, the stock has lost 8.18% in 2025, and is trading 1.49% lower in the last five trading sessions. The company shares hit their year-high levels at ₹ 494.95 on 25 July 2024, while the year-low level was at ₹ 241 on 7 April 2025, according to the data collected from the BSE website. The hotel chain's market capitalisation (M-Cap) was at ₹ 6,888.78 crore as of the stock market close on Thursday, 3 July 2025. The BSE data also showed that the company's Price to Earnings (PE) ratio was greater than 50 for the previous four trailing quarters. This may likely mean that higher growth expectations from stock market investors, an asset-rich business, or maybe even a potential overvaluation in the current market. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
The Print
5 hours ago
- The Print
Stock markets decline on fag-end selling; financial stocks drag
The 50-share NSE Nifty declined by 48.10 points or 0.19 per cent to 25,405.30. The 30-share BSE Sensex dropped by 170.22 points or 0.20 per cent to settle at 83,239.47. The index opened higher and rose further by 440.4 points or 0.52 per cent to hit a high of 83,850.09. However, profit taking emerged in the last hour of trade dragging the barometer to a low of 83,186.74 in the pre-close session. Mumbai, Jul 3 (PTI) Benchmark stock indices Sensex and Nifty pared intra-day gains to close lower on Thursday due to last-hour selling in financial and metal shares. Among the Sensex firms, Kotak Mahindra Bank, Bajaj Finserv, Bajaj Finance, Adani Ports, Trent, State Bank of India, Titan and Tata Consultancy Services were the laggards. However, Maruti, Infosys, NTPC, Asian Paints, Eternal and Hindustan Unilever were among the biggest gainers. 'Markets traded volatile on the weekly expiry day and ended marginally lower, continuing the ongoing consolidation phase,' Ajit Mishra – SVP, Research, Religare Broking Ltd said. Sector-wise, the trend remained mixed — auto and pharma posted gains, while metal and realty were among the top losers, he added. The broader indices also mirrored this movement and closed on a flat note. The BSE smallcap gauge climbed 0.47 per cent while midcap index dipped 0.06 per cent. Among BSE sectoral indices, services dropped the most by 1.08 per cent, followed by metal (0.77 per cent), realty (0.61 per cent), telecommunication (0.55 per cent), utilities (0.48 per cent) and bankex (0.48 per cent). Healthcare, consumer discretionary, auto, consumer durables and oil & gas were the gainers. Vinod Nair, Head of Research, Geojit Investments Limited, said that investors remain watchful of developments surrounding the potential US-India trade agreement, with the 90-day pause nearing its end. FIIs have turned cautious in the recent days due to premium valuation. In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index and Shanghai's SSE Composite index settled higher while Hong Kong's Hang Seng ended lower. European markets were trading on a mixed note. The US markets ended mostly higher on Wednesday. The Indian services sector growth touched a ten-month high in June aided by robust expansion in international sales and job creation, amid positive demand trends and ongoing improvement in sales, a monthly survey said on Thursday. The seasonally adjusted HSBC India Services PMI Business Activity Index rose from 58.8 in May to 60.4 in June, driven by sharp upturn in new business orders. In the Purchasing Managers' Index (PMI) parlance, a print above 50 means expansion, while a score below 50 denotes contraction. Global oil benchmark Brent crude declined 1.03 per cent to USD 68.40 a barrel. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 1,561.62 crore on Wednesday, according to exchange data. On Wednesday, the BSE Sensex ended 287.60 points or 0.34 per cent lower at 83,409.69. The Nifty declined by 88.40 points or 0.35 per cent to settle at 25,453.40. PTI SUM MR MR This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
&w=3840&q=100)
Business Standard
7 hours ago
- Business Standard
Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report
United States-based private equity firm Carlyle Group is planning to divest up to 10 per cent stake in Piramal Pharma through block deals, Moneycontrol reported on Thursday, citing sources. The sale could amount to ₹2,600-2,700 crore, the report added. Piramal Pharma sold 20 per cent of its stake to Carlyle Group in June 2020, in a deal worth ₹3,523 crore. According to stock exchange data, it held 18 per cent stake in the pharma firm as of March 31, 2025. Financial services firm Motilal Oswal has been roped in to facilitate the block deals, the report added. Piramal Pharma operates a diverse and global pharmaceutical business, providing a broad range of products and services. It includes Piramal Pharma Solutions (PPS), a fully integrated contract development and manufacturing organisation (CDMO); Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products. Piramal Pharma Q4 result In the fourth quarter of FY25, Piramal Pharma posted a consolidated revenue from operations of ₹2,754 crore, marking an 8 per cent increase over the ₹2,552 crore recorded in the same quarter last year. The company's EBITDA (earnings before interest, tax, depreciation, and amortisation) also increased by 8 per cent year-on-year to ₹603 crore, up from ₹556 crore. Profit after tax (before exceptional items) came in at ₹154 crore, reflecting a 16 per cent rise compared to ₹132 crore in the corresponding period of the previous financial year. Shares of Piramal Pharma last traded at ₹202.4 apiece on the BSE at the close of the markets on Thursday.
